|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Van Cutsem E, Sagaert X, Topal B,
Haustermans K and Prenen H: Gastric cancer. Lancet. 388:2654–2664.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Charalampakis N, Economopoulou P,
Kotsantis I, Tolia M, Schizas D, Liakakos T, Elimova E, Ajani JA
and Psyrri A: Medical management of gastric cancer: A 2017 update.
Cancer Med. 7:123–133. 2018. View Article : Google Scholar :
|
|
4
|
Sitarz R, Skierucha M, Mielko J, Offerhaus
GJA, Maciejewski R and Polkowski WP: Gastric cancer: Epidemiology,
prevention, classification, and treatment. Cancer Manag Res.
10:239–248. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Araújo R, Santos JM, Fernandes M, Dias F,
Sousa H, Ribeiro J, Bastos MM, Oliveira PA, Carmo D, Casaca F, et
al: Expression profile of microRNA-146a along HPV-induced multistep
carcinogenesis: A study in HPV16 transgenic mice. J Cancer Res Clin
Oncol. 144:241–248. 2018. View Article : Google Scholar
|
|
6
|
Dehghanzadeh R, Jadidi-Niaragh F, Gharibi
T and Yousefi M: MicroRNA-induced drug resistance in gastric
cancer. Biomed Pharmacother. 74:191–199. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mohammadi A, Mansoori B and Baradaran B:
The role of microRNAs in colorectal cancer. Biomed Pharmacother.
84:705–713. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang R, Li P, Zhang G, Lu C, Wang H and
Zhao G: Long non-coding RNA XLOC_008466 functions as an oncogene in
human non-small cell lung cancer by targeting miR-874. Cell Physiol
Biochem. 42:126–136. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shea A, Harish V, Afzal Z, Chijioke J,
Kedir H, Dusmatova S, Roy A, Ramalinga M, Harris B, Blancato J, et
al: MicroRNAs in glioblastoma multiforme pathogenesis and
therapeutics. Cancer Med. 5:1917–1946. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jin F, Wang Y, Li M, Zhu Y, Liang H, Wang
C, Wang F, Zhang CY, Zen K and Li L: MiR-26 enhances
chemosensitivity and promotes apoptosis of hepatocellular carcinoma
cells through inhibiting autophagy. Cell Death Dis. 8:e25402017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang B, Ji S, Ma F, Ma Q, Lu X and Chen
X: miR-489 acts as a tumor suppressor in human gastric cancer by
targeting PROX1. Am J Cancer Res. 6:2021–2030. 2016.PubMed/NCBI
|
|
12
|
Wei T, Zhu W, Fang S, Zeng X, Huang J,
Yang J, Zhang J and Guo L: miR-495 promotes the chemoresistance of
SCLC through the epithelial-mesenchymal transition via Etk/BMX. Am
J Cancer Res. 7:628–646. 2017.PubMed/NCBI
|
|
13
|
Riquelme I, Letelier P, Riffo-Campos AL,
Brebi P and Roa JC: Emerging Role of miRNAs in the Drug Resistance
of Gastric Cancer. Int J Mol Sci. 17:4242016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Çalışkan M, Güler H and Bozok Çetintaş V:
Current updates on microRNAs as regulators of chemoresistance.
Biomed Pharmacother. 95:1000–1012. 2017. View Article : Google Scholar
|
|
15
|
Nohata N, Hanazawa T, Kinoshita T, Inamine
A, Kikkawa N, Itesako T, Yoshino H, Enokida H, Nakagawa M, Okamoto
Y, et al: Tumour-suppressive microRNA-874 contributes to cell
proliferation through targeting of histone deacetylase 1 in head
and neck squamous cell carcinoma. Br J Cancer. 108:1648–1658. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Que K, Tong Y, Que G, Li L, Lin H, Huang
S, Wang R and Tang L: Downregulation of miR-874-3p promotes
chemotherapeutic resistance in colorectal cancer via inactivation
of the Hippo signaling pathway. Oncol Rep. 38:3376–3386.
2017.PubMed/NCBI
|
|
17
|
Wang L, Gao W, Hu F, Xu Z and Wang F:
MicroRNA-874 inhibits cell proliferation and induces apoptosis in
human breast cancer by targeting CDK9. FEBS Lett. 588:4527–4535.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang X, Tang J, Zhi X, Xie K, Wang W, Li
Z, Zhu Y, Yang L, Xu H and Xu Z: miR-874 functions as a tumor
suppressor by inhibiting angiogenesis through STAT3/VEGF-A pathway
in gastric cancer. Oncotarget. 6:1605–1617. 2015.PubMed/NCBI
|
|
19
|
Brierley JD, Gospodarwicz MK and Wittekind
C: TNM classification of maligant tumours. 8th edition. Wiley
Blackwell; Oxford: 2017
|
|
20
|
Amin MB, Edge SB, Greene FL and Brierley
JD: AJCC cancer staging manual. 8th edition. Springer; New York:
2017, View Article : Google Scholar
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
22
|
Lu Y, Gao J, Zhang S, Gu J, Lu H, Xia Y,
Zhu Q, Qian X, Zhang F, Zhang C, et al: miR-142-3p regulates
autophagy by targeting ATG16L1 in thymic-derived regulatory T cell
(tTreg). Cell Death Dis. 9:2902018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee KW, Lee JH, Kim JW, Kim JW, Ahn S and
Kim JH: Population-based outcomes research on treatment patterns
and impact of chemotherapy in older patients with metastatic
gastric cancer. J Cancer Res Clin Oncol. 142:687–697. 2016.
View Article : Google Scholar
|
|
24
|
Annovazzi L, Mellai M and Schiffer D:
Chemotherapeutic drugs: DNA damage and repair in glioblastoma.
Cancers (Basel). 9:572017. View Article : Google Scholar
|
|
25
|
Adamska A, Elaskalani O, Emmanouilidi A,
Kim M, Abdol Razak NB, Metharom P and Falasca M: Molecular and
cellular mechanisms of chemoresistance in pancreatic cancer. Adv
Biol Regul. 68:77–87. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bourguignon LY, Earle C and Shiina M:
Activation of matrix hyaluronan-mediated CD44 signaling, epigenetic
regulation and chemoresistance in head and neck cancer stem cells.
Int J Mol Sci. 18:182017. View Article : Google Scholar
|
|
27
|
Butera G, Pacchiana R and Donadelli M:
Autocrine mechanisms of cancer chemoresistance. Semin Cell Dev
Biol. 78:3–12. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
de Oliveira Júnior RG, Christiane Adrielly
AF, da Silva Almeida JR, Grougnet R, Thiéry V and Picot L:
Sensitization of tumor cells to chemotherapy by natural products: A
systematic review of preclinical data and molecular mechanisms.
Fitoterapia. 129:383–400. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang K, Chen J, Zhou H, Chen Y, Zhi Y,
Zhang B, Chen L, Chu X, Wang R and Zhang C: PU1/microRNA-142-3p
targets ATG5/ATG16L1 to inactivate autophagy and sensitize
hepato-cellular carcinoma cells to sorafenib. Cell Death Dis.
9:3122018. View Article : Google Scholar
|
|
30
|
Bhat P, Kriel J, Shubha Priya B, Basappa,
Shivananju NS and Loos B: Modulating autophagy in cancer therapy:
Advancements and challenges for cancer cell death sensitization.
Biochem Pharmacol. 147:170–182. 2018. View Article : Google Scholar
|
|
31
|
Sannigrahi MK, Singh V, Sharma R, Panda NK
and Khullar M: Role of autophagy in head and neck cancer and
therapeutic resistance. Oral Dis. 21:283–291. 2015. View Article : Google Scholar
|
|
32
|
Gao Wu J, Xu F, Deng T, Wang X, Yang C, Hu
X, Long Z, He Y, Liang XG, et al: miR-503 suppresses the
proliferation and metastasis of esophageal squamous cell carcinoma
by triggering autophagy via PKA/mTOR signaling. Int J Oncol. Mar
16–2018.Epub ahead of print. View Article : Google Scholar
|
|
33
|
Wang S, Kobeissi A, Dong Y, Kaplan N, Yang
W, He C, Zeng K and Peng H: MicroRNAs-103/107 regulate autophagy in
the epidermis. J Invest Dermatol. 138:1481–1490. 2018. View Article : Google Scholar : PubMed/NCBI
|
